DOCSLIB.ORG

Physiological Effects of Caffeine and Its Congeners Present in Tea And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2018 doi:10.20944/preprints201808.0032.v1 1 Type of the paper: Review 2 3 Physiological effects of caffeine and its congeners 4 present in tea and coffee beverages 5 6 I. Iqbal1, M. N. Aftab2, M. A. Safer3, M. Menon4, M. Afzal5⌘ 7 1Department of Life Sciences, Lahore College for Women, Lahore, Pakistan 8 2Institute of Biochemistry and Biotechnology, Government College University, 9 Lahore 54000, Pakistan 10 3Department of Biological Sciences, Faculty of Science, Kuwait University, Kuwait 11 4Plamer University (West Campus) San Jose, CA 12 5Department of Biological Sciences, Faculty of Science, Kuwait University, Kuwait 13 ⌘ Correspondence: [email protected], Tel. +1 352 681 7347 14 15 16 Running title: Caffeine 17 18 19 20 21 22 23 Corresponding author: 24 M. Afzal, 25 10547 NW 14th PL. 26 Gainesville, FL. USA 27 email: [email protected] 28 Tel. +1 352 681 7347 29 30 1 © 2018 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2018 doi:10.20944/preprints201808.0032.v1 31 Abstract: Tea and coffee are the most commonly used beverages throughout the 32 world. Both decoctions are rich in small organic molecules such as 33 phenolics/polyphenolics, purine alkaloids, many methylxanthines, substituted 34 benzoic and cinnamic acids. Many of these molecules are physiologically 35 chemopreventive and chemoprotective agents against many severe conditions such 36 as cancer, Alzheimer, Parkinsonism, inflammation, sleep apnea, cardiovascular 37 disorders, bradycardia, fatigue, muscular relaxation, and oxidative stress. Caffeine, a 38 purine alkaloid, is a common metabolite of both tea and coffee aqueous decoctions 39 and its concentration in tea/coffee depends on the fermentation process, 40 preparation of the water extract and quality of tea leaves/coffee beans. A 250 ml of a 41 coffee cup contains 100-150 mg caffeine while the same volume of strong tea 42 contains 25-40 mg caffeine. The present paper presents the potential of caffeine as 43 a potent chemopreventive agent that can be used for numerous physiological 44 disorders. 45 46 Keywords: Caffeine, methylxanthine, chlorogenic acid, caffeic acid, inflammation, 47 antimutagen, anticancer, antioxidant. 48 49 50 51 2 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2018 doi:10.20944/preprints201808.0032.v1 52 1. Introduction 53 Caffeine from cocoa beans was first discovered in Ethiopia, and since then it has been 54 a part of the global history for thousands of years. German scientist Friedrich Ferdinand 55 Runge was the first to isolate pure caffeine in 1820 and the word caffeine is derived from 56 the German word ‘Kaffee’ and the French word ‘Café.' Since then, the psychoactive 57 substance caffeine is one of the most researched medications with more than 30,200 58 research publications. During 2016 more than 2000, while in 2017 in access of 1200, and 59 in 2018 till March, more 300 publications have appeared on different aspects of caffeine. 60 This data shows the global research interest in caffeine and related methylxanthines. On a 61 daily basis, around the world, more than two billion cups of tea and coffee are consumed 62 making it the most frenzied beverage after water and the second most traded commodity 63 after oil when both are deliberated as black gold. Due to its diverse pharmacological 64 activities, caffeine merits a focus for further scientific research. 65 The black decoction of coffee contains hundreds of compounds, the composition, and 66 concentration of which depends upon many factors including cultivar, the origin of coffee 67 and the method of its preparation. Roasting of coffee beans results in about 1000 volatile 68 compounds, and 35 aroma compounds and caffeine is a common metabolite in both tea 69 leaves and coffee bean. On the average, tea leaves contain 3% caffeine depending upon 70 the tea quality and method of its preparation. An 8 fl oz. cup of coffee contains 100-150 71 mg caffeine while black and green tea provides 40-60 mg and 25-40 mg of caffeine, 72 respectively. The total phenolic content of varies 19.2-108.6 mg mL-1 with an abundance 73 of quinic acid and gallic acids (1). The seasonal variation of theanine, methylxanthines, 74 and catechins such as Afzelechin (1a), in 21 cultivars of Camellia Sinensis, has been 75 recently published [1, 1a]. 76 Caffeine, a 1,3,7-trimethylxanthine (C8H10N4O2), purine alkaloid (2) and structurally 77 related to adenosine (5), has an astringent taste. It is produced in more than 60 distantly 78 related plant species such as coffee beans, tea leaves, kola nuts (Cola acuminate, Beauv 79 and Cola nitida, Vent), cocoa beans (Theobroma cacao) and even in some citrus species 80 [2]. In some cases, methylxanthines are recognized as remarkable markers for facilitating 81 chemotaxonomy of plants while caffeine (2), theophylline (17), saxitoxin, and 82 theobromine (4) are the representative examples of this class of methylxanthines. 3 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2018 doi:10.20944/preprints201808.0032.v1 83 The bitter taste of black tea (Camellia Sinensis) and roasted coffee (two species of 84 Coffee; C. arabica and C. robusta), is recognized due to the variable amounts of caffeine 85 and 5-caffeoylquinic acid (6). A link between the mouth cavity, nasal cavity, and the 86 brain is known, and caffeine can cross the blood-brain barrier [3]. 87 OH O CH3 H C 3 N HO O N N O N OH 88 HO CH3 89 (1) (2) 90 O CH3 NH2 H H N HO N N O N O O N 91 CH3 92 (3) (4) 93 94 NH2 OH N N HO OH O N O N OH H HO O O O H 95 HO OH HO 96 97 (5) (6) 98 99 4 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2018 doi:10.20944/preprints201808.0032.v1 100 Caffeine is frequently used as a CNS stimulant with numerous physiological 101 consequences on cardiovascular, renal, respiratory, immuno-modulation, smooth muscle, 102 mood forming, memory, alertness, and cognitive performance [4]. Due to their ergogenic 103 effect, caffeine and creatine (10) are the two most widely used compounds in sports with 104 a sizeable interindividual variation of caffeine absorption within and between groups [5]. 105 As complex forming agents, methylxanthines, like caffeine can interact with lysozyme, 106 bringing about a conformational change in the cationic proteins, thus lowering the 107 antimicrobial activity. Synergistic cytotoxicity and mechanism of caffeine and lysozyme 108 on hepatoma cells have been recently reported [6]. 109 Tea and coffee extract, apart from methylxanthines, contain many other 110 phytochemicals such as L-theanine (N-ethyl-L-glutamine) (3) that also affect mood, 111 cognition, sustained attention and suppression of distraction [7]. Theanine enhances the 112 toxicity when combined with strychnine or phenobarbital sodium [8]. The other tea 113 congener, theobromine (4), is an inhibitor of physiologically essential phosphodiesterases 114 and it increases intracellular second messenger molecules cAMP and cGMP in mice [9]. 115 In green coffee beans, along with caffeine, chlorogenic acid, the most popular weight loss 116 ingredient and its derivatives have also been identified [10]. 117 While hot tea and coffee extracts contain variable amounts of caffeine, heating, and 118 processing of coffee beans convert 5-caffeoylquinic acid (neochlorogenic acid, 6) into 119 various phenylindanes (7) and lactones such as 3-caffeoylquinic-1,5-lactone (8) and 4- 120 caffeoylquinic-1,5-lactone (9) [11]. Melanoidins, present in coffee, are the byproducts 121 produced by Millard reaction between amino groups of proteins and carbonyl groups of 122 reducing sugars and are poorly understood [12]. This convolution of the tea and coffee 123 extracts shows a highly complicated mixture of hundreds of small molecules that have 124 not even been investigated. 5 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2018 doi:10.20944/preprints201808.0032.v1 CH3 O HO O 1 O 2 HO 3 OH HO O 6 5 4 HO OH R OH 125 OH 126 127 (7) (8) 128 129 130 O 1 O 3 2 NH O OH HO 6 HO HO 5 O 4 N NH2 O CH 131 HO 3 132 133 (9) (10) 134 135 136 137 2. Caffeine: Bioavailability and dose response 138 For healthy adults, the recommended amount of caffeine is around 400 mg/day, and 139 an overdose may occur if one absorbs more than this amount. A moderate dose of 140 caffeine may cause anxiety in consumers, and it can lead to central nervous system 141 consequences in heavy consumers. Liver diseases, pregnancy, oral use of contraceptives, 142 and interaction with therapeutic drugs may lower the metabolism and its excretion 143 consequently increasing its concentration in the body. The safe amount of caffeine differs 144 for everyone, and it depends on age, weight, gender and the state of general health. These 145 variables make it difficult to know the exact amount of caffeine that can lead to an 6 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2018 doi:10.20944/preprints201808.0032.v1 146 overdose or an inevitable consequence. Therefore, at a young age, a dose of 100 mg/day 147 is safer. 148 The half-life of caffeine (HLC) is species dependent and is recorded as 3-5 hr. Thus, 149 in an adult human, HLC is 0.7-1.0 hr., rats, and mice, 1-1.6 hr., rabbits 3-5 hr., monkeys, 150 and baboons, 4-4.3 hr., while in dogs it is 11-12 hr [13].
Recommended publications
  • Additions and Deletions to the Drug Product List

    Additions and Deletions to the Drug Product List

    Prescription and Over-the-Counter Drug Product List 40TH EDITION Cumulative Supplement Number 09 : September 2020 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >A> AA STRIDES PHARMA 325MG;50MG;40MG A 203647 001 Sep 21, 2020 Sep NEWA ACETAMINOPHEN; CODEINE PHOSPHATE SOLUTION;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >D> AA WOCKHARDT BIO AG 120MG/5ML;12MG/5ML A 087006 001 Jul 22, 1981 Sep DISC >A> @ 120MG/5ML;12MG/5ML A 087006 001 Jul 22, 1981 Sep DISC TABLET;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >A> AA NOSTRUM LABS INC 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >A> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >A> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN >D> AA TEVA 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >D> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >D> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET;ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> @ CEROVENE INC 325MG;5MG A 211690 001 Feb 07, 2020 Sep CAHN >A> @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Sep CAHN >A> @ 325MG;10MG A 211690 003 Feb 07, 2020 Sep CAHN >D> AA VINTAGE PHARMS 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >A> @ 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >D> AA 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >A> @ 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >D> AA 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >A> @ 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >D> @ XIROMED 325MG;5MG A 211690
  • Coffee and Its Effect on Digestion

    Coffee and Its Effect on Digestion

    Expert report Coffee and its effect on digestion By Dr. Carlo La Vecchia, Professor of Medical Statistics and Epidemiology, Dept. of Clinical Sciences and Community Health, Università degli Studi di Milano, Italy. Contents 1 Overview 2 2 Coffee, a diet staple for millions 3 3 What effect can coffee have on the stomach? 4 4 Can coffee trigger heartburn or GORD? 5 5 Is coffee associated with the development of gastric or duodenal ulcers? 6 6 Can coffee help gallbladder or pancreatic function? 7 7 Does coffee consumption have an impact on the lower digestive tract? 8 8 Coffee and gut microbiota — an emerging area of research 9 9 About ISIC 10 10 References 11 www.coffeeandhealth.org May 2020 1 Expert report Coffee and its effect on digestion Overview There have been a number of studies published on coffee and its effect on different areas of digestion; some reporting favourable effects, while other studies report fewer positive effects. This report provides an overview of this body of research, highlighting a number of interesting findings that have emerged to date. Digestion is the breakdown of food and drink, which occurs through the synchronised function of several organs. It is coordinated by the nervous system and a number of different hormones, and can be impacted by a number of external factors. Coffee has been suggested as a trigger for some common digestive complaints from stomach ache and heartburn, through to bowel problems. Research suggests that coffee consumption can stimulate gastric, bile and pancreatic secretions, all of which play important roles in the overall process of digestion1–6.
  • Coffee and Liver Diseases

    Coffee and Liver Diseases

    Fitoterapia 81 (2010) 297–305 Contents lists available at ScienceDirect Fitoterapia journal homepage: www.elsevier.com/locate/fitote Review Coffee and liver diseases Pablo Muriel ⁎, Jonathan Arauz Departamento de Farmacología, Cinvestav-IPN., Apdo. Postal 14-740, México 07000, D.F., Mexico article info abstract Article history: Coffee consumption is worldwide spread with few side effects. Interestingly, coffee intake has Received 26 August 2009 been inversely related to the serum enzyme activities gamma-glutamyltransferase, and alanine Accepted in revised form 25 September 2009 aminotransferase in studies performed in various countries. In addition, epidemiological Available online 13 October 2009 results, taken together, indicate that coffee consumption is inversely related with hepatic cirrhosis; however, they cannot demonstrate a causative role of coffee with prevention of liver Keywords: injury. Animal models and cell culture studies indicate that kahweol, diterpenes and cafestol Coffee (some coffee compounds) can function as blocking agents by modulating multiple enzymes Hepatic injury involved in carcinogenic detoxification; these molecules also alter the xenotoxic metabolism by Fibrosis Cirrhosis inducing the enzymes glutathione-S-transferase and inhibiting N-acetyltransferase. Drinking Cancer coffee has been associated with reduced risk of hepatic injury and cirrhosis, a major pathogenic step in the process of hepatocarcinogenesis, thus, the benefit that produces coffee consumption on hepatic cancer may be attributed to its inverse relation with cirrhosis, although allowance for clinical history of cirrhosis did not completely account for the inverse association. Therefore, it seems to be a continuum of the beneficial effect of coffee consumption on liver enzymes, cirrhosis and hepatocellular carcinoma. At present, it seems reasonable to propose experiments with animal models of liver damage and to test the effect of coffee, and/or isolated compounds of this beverage, not only to evaluate the possible causative role of coffee but also its action mechanism.
  • Neonatal Intensive Care Drug Therapy Update: a Bibliography

    Neonatal Intensive Care Drug Therapy Update: a Bibliography

    LWW/JPNN AS310-13 July 28, 2004 23:11 Char Count= 0 J Perinat Neonat Nurs Vol. 18, No. 3, pp. 292–306 c 2004 Lippincott Williams & Wilkins, Inc. Neonatal Intensive Care Drug Therapy Update: A Bibliography Jason Sauberan, PharmD BIBLIOGRAPHY I. Overview A. Clark RH, Bloom BT, Gerstmann DR Medications Used in Neonatal Intensive Care Units—A Descriptive Study [abstract 3047]. In: Program and abstracts of the 2004 Pediatric Academic Societies’ Annual Meeting, San Francisco, CA. B. Barr J, Brenner-Zada G, Heiman E, Pareth G, Bulkowstein M, Greenberg R, Berkovitch M. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol. 2002 Feb;19(2):67–72. C. O’Donnell CP, Stone RJ, Morley CJ. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics. 2002 Nov;110(5):e52. D. Committee on Drugs. American Academy of Pediatrics. Uses of drugs not described in the package insert (off-label uses). Pediatrics. 2002 Jul;110(1 Pt 1):181–3. II. Anti-infectives A. Linezolid 1. Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S158–63. 2. Vo M, Cirincione BB, Rubino CM, Jungbluth GL. Pharmacokinetics of Linezolid in Neonates and Young Infants [abstract A-1409]. In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA.
  • Effect of Aminophylline on Diaphragmatic Contractility in the Piglet

    Effect of Aminophylline on Diaphragmatic Contractility in the Piglet

    003 1-3998/90/2803-0196$02.00/0 PEDIATRIC RESEARCH Vol. 28, No. 3, 1990 Copyright 0 1990 International Pediatric Research Foundation, Inc. Printed in (I.S.A. Effect of Aminophylline on Diaphragmatic Contractility in the Piglet DENNIS E. MAYOCK, THOMAS A. STANDAERT, JON F. WATCHKO, AND DAVID E. WOODRUM1 University of Washington School of Medicine, Department of Pediatrics, Division of Neonatal and Respiratory Diseases, Seattle, Washington 98195 ABSTRACT. Minute ventilation, arterial blood gases, ar- of arterial oxygen > 8 kPa (60 torr) in room air, and a partial terial pH, cardiac output, and transdiaphragmatic force pressure of the arterial carbon dioxide 5 6.7 kPa (50 torr) were generation, both during spontaneous ventilation and in accepted for study. The animals were anesthetized with an i.v. response to phrenic nerve stiwulation during airway occlu- combination of chloralose (30 mg/kg) and urethane (1 50 mg/ sion at end expiration, were measured in nine anesthetized, kg) and studied in the supine position. Subsequent infusions of tracheostomized piglets before and 30 min after parenteral anesthetic were used if the piglet developed jaw clonus. A trache- infusion of 20 mg/kg aminophylline. Serum theophylline ostomy was placed and connected to a two-way nonrebreathing levels averaged 109 f 21 ~mol/L(19.7 f 3.7 ~g/mL)at valve (model 2384, Hans Rudolph, Inc., Kansas City, MO). 30 min postinfusion. No significant changes were noted in Inspiratory flow was detected by a hot-wire anemometer and pH, blood gases, blood Pressure, or ventilatory measures integrated to provide tidal volume. All animals breathed 50% after aminophylline.
  • An Investigation of the Voltammetric Behaviour of Antioxidants in Flavonoids

    An Investigation of the Voltammetric Behaviour of Antioxidants in Flavonoids

    AN INVESTIGATION OF THE VOLTAMMETRIC BEHAVIOUR OF ANTIOXIDANTS IN FLAVONOIDS By Lee-Ann Ramsarup Student Number: 20427580 Submitted in fulfilment of the requirements for the degree of Master of Applied Science in Chemistry in the Faculty of Applied Sciences at the Durban University of Technology April 2020 DECLARATION I, Lee-Ann Ramsarup, hereby declare that the work presented in this thesis entitle “An Investigation of the Voltammetric Behaviour of Antioxidants in Flavonoids” has not been submitted to any other University or Institution for any degree or examination. This is my own work and where the work of others was used, it was to the best of my knowledge accurately reported and duly acknowledged. Signature of Lee-Ann Ramsarup (Student) Date Signature of Prof Krishna Bisetty (Supervisor) Date Signature of Dr Suvardhan Kanchi (Co- Supervisor) Date i DEDICATION This work is dedicated to my late uncle, Gayson Samuel. I am thankful for his presence and support throughout my life. His memory lives on forever. ii ACKNOWLEDGMENTS All that I have and all that I am is because of my Lord and Saviour Jesus Christ. All honour and glory to Him for giving me the strength and faith to see this project to completion. I wish to express my sincere appreciation to my Supervisor, Prof Krishna Bisetty for his assistance and constant motivation throughout my research. I extend my heartfelt appreciation to my Co-Supervisor, Dr Suvardhan Kanchi for his time, support and direction during this journey. Special thanks to Dr Myalo I Sabela (Lecturer) and Nokukhanya Xhakaza (Technician) for assisting me with their time and experience during the experimental phase of the research work.
  • Aminophylline Catalog Number A1755 Storage

    Aminophylline Catalog Number A1755 Storage

    Aminophylline Catalog Number A1755 Storage Temperature –20 °C Replacement for Catalog Number 216895 CAS RN 317-34-0 Storage/Stability Synonyms: theophylline hemiethylenediamine complex; Aminophylline should be kept tightly closed to prevent 3,7-dihydro-1,3-demethyl-1H-purine-2,6-dione CO2 absorption from the atmosphere, which leads to compound with 1,2-ethanediamine (2:1); formation of theophylline and decreased solubility in 1,2 3 (theophylline)2 • ethylenediamine aqueous solutions. Stock solutions should be protected from light and prevented from contact with Product Description metals.2 Molecular Formula: C7H8N4O2 ·1/2 (C2H8N2) Molecular Weight: 210.3 References 1. The Merck Index, 12th ed., Entry# 485. Aminophylline is a xanthine derivative which is a 2. Martindale: The Extra Pharmacopoeia, 31st ed., combination of theophylline and ethylenediamine that is Reynolds, J. E. F., ed., Royal Pharmaceutical more water soluble than theophylline alone. Society (London, England: 1996), pp. 1651-1652. Aminophylline has been widely used as an inhibitor of 3. Data for Biochemical Research, 3rd ed., Dawson, cAMP phosphodiesterase.3 R. M. C., et al., Oxford University Press (New York, NY: 1986), pp. 316-317. Aminophylline has been shown to limit 4. Pelech, S. L., et al., cAMP analogues inhibit phosphatidylcholine biosynthesis in cultured rat phosphatidylcholine biosynthesis in cultured rat hepatocytes.4 It has been used in studies of acute hepatocytes. J. Biol. Chem., 256(16), 8283-8286 hypoxemia in newborn and older guinea pigs.5 The (1981). effect of various xanthine derivatives, including 5. Crisanti, K. C., and Fewell, J. E., Aminophylline aminophylline, on activation of the cystic fibrosis alters the core temperature response to acute transmembrane conductance regulator (CFTR) chloride hypoxemia in newborn and older guinea pigs.
  • Rosemary)-Derived Ingredients As Used in Cosmetics

    Rosemary)-Derived Ingredients As Used in Cosmetics

    Safety Assessment of Rosmarinus Officinalis (Rosemary)-Derived Ingredients as Used in Cosmetics Status: Tentative Amended Report for Public Comment Release Date: March 28, 2014 Panel Meeting Date: June 9-10, 2014 All interested persons are provided 60 days from the above release date to comment on this safety assessment and to identify additional published data that should be included or provide unpublished data which can be made public and included. Information may be submitted without identifying the source or the trade name of the cosmetic product containing the ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or requests to the CIR Director, Dr. Lillian J. Gill. The 2014 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This safety assessment was prepared by Monice M. Fiume, Assistant Director/Senior Scientific Analyst. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200♢ Washington, DC 20036 ♢ ph 202.331.0651 ♢ fax 202.331.0088 ♢ [email protected] TABLE OF CONTENTS Abstract ......................................................................................................................................................................................................................................
  • Application and Review of Pediatric Pharmacotherapy, Sample Chapter

    Application and Review of Pediatric Pharmacotherapy, Sample Chapter

    Application and Review of Pediatric Pharmacotherapy Chapter No. 1 Dated: 29/7/2010 At Time: 16:16:4 Section 1 Neonatal intensive care “Luck is where preparation meets opportunity.” This section consists of 16 medication orders followed by corresponding patient profiles representing pharmacotherapy associated with patients admit- ted to a neonatal intensive care unit. Each patient profile is followed by multiple-choice questions pertaining to the medication order and profile infor- mation. Choose the one best-lettered response to each item. The correct answers are provided at the end of this section. The reader is encouraged to attempt all questions for each case or for the entire section prior to referring to the answers. Moreover, where appropriate, the answer key provides a thor- ough explanation of the correct response and should serve as an additional learning tool for the reader. Application and Review of Pediatric Pharmacotherapy Chapter No. 1 Dated: 29/7/2010 At Time: 16:16:4 2 | Application and Review of Pediatric Pharmacotherapy Medication orders Physician order Patient weight: 2.5 kg Aminophylline 10 mg iv load, then begin 2.5 mg iv q 12 h Obtain theophylline concentration 1 h postinfusion of loading dose Date/time: 12/01/2100 Patient name: Baby Boy Turner Physician: John Craver Patient ID: 111222 Medical profile Patient: Baby Boy Turner Patient weight: 2.5 kg Age: 1d/o Present illness: Apneic episodes Allergies: None Medical history: 33 weeks gestation, Apgar 7 and 9 Labs: pending Medication profile Questions Q1 Which of the following is an acceptable definition of apnea of prematurity? 1 o cessation of breathing for less than 20 s 2 o cessation of breathing for at least 20 s 3 o cessation of breathing for less than 20 s when accompanied by bradycardia A o 1 only B o 3 only C o 1 and 3 only Application and Review of Pediatric Pharmacotherapy Chapter No.
  • Caffeine in the Treatment of Pain

    Caffeine in the Treatment of Pain

    Rev Bras Anestesiol ARTIGOS DE REVISÃO 2012; 62: 3: 387-401 ARTIGOS DE REVISÃO Cafeína para o Tratamento de Dor Cristiane Tavares, TSA 1, Rioko Kimiko Sakata, TSA 2 Resumo: Tavares C, Sakata RK – Cafeína para o Tratamento de Dor. Justificativa e objetivos: A cafeína é uma substância amplamente consumida com efeitos em diversos sistemas e que apresenta farmacoci- nética e farmacodinâmica características, causando interações com diversos medicamentos. O objetivo deste estudo é fazer uma revisão sobre os efeitos da cafeína. Conteúdo: Nesta revisão, são abordados a farmacologia da cafeína, os mecanismos de ação, as indicações, as contraindicações, as doses, as interações e os efeitos adversos. Conclusões: Faltam estudos controlados, randomizados e duplos-cegos para avaliar a eficácia analgésica da cafeína nas diversas síndromes dolorosas. Em pacientes com dor crônica, é necessário ter cautela em relação ao desenvolvimento de tolerância, abstinência e interação medi- camentosa no uso crônico de cafeína. Unitermos: ANALGESIA; DOR; DROGAS, Alcaloide/cafeína. ©2012 Elsevier Editora Ltda. Todos os direitos reservados. INTRODUÇÃO Estrutura química A cafeína foi isolada em 1820, mas a estrutura correta des- A cafeína é um alcaloide presente em mais de 60 espécies ta metilxantina foi estabelecida na última década do século de plantas 4. Sua estrutura molecular pertence a um grupo XIX. Os efeitos não foram claramente reconhecidos até 1981, de xantinas trimetiladas que incluem seus compostos inti- quando o bloqueio de receptores adenosina foi correlacio- mamente relacionados: teobromina (presente no cacau) e nado às propriedades estimulantes da cafeína e de seus teofilina (presente no chá) 1. Quimicamente, esses alcaloides análogos 1. Provavelmente a cafeína é uma das substâncias são semelhantes a purinas, xantinas e ácido úrico, que são psicoativas mais utilizadas no mundo, promovendo efeitos compostos metabolicamente importantes 4.
  • Coffee, Tea, Or Caffeine-Free?

    Coffee, Tea, Or Caffeine-Free?

    SPECIAL REPORT: Coffee, Tea, or Caffeine-Free? Copyright 2016 by David L. Meinz, MS, RDN, FAND, CSP www.DavidMeinz.com Americans drink a whopping 500 million cups of coffee every day. That comes to over six billion gallons a year. That’s more than any other country in the world. It’s been our national drink ever since the Boston Tea Party. Coffee accounts for about 75% of the caffeine we take in and about nine out of ten Americans take caffeine in everyday in one form or another. The average American coffee drinker says they take in about 3 ½ cups per day. And the surprising good news about coffee is that there is very little bad news. The coffee bean, like all plants, contains many different naturally occuring compounds and chemicals. Some of those are the good antioxidants that help our body protect itself from damage. As a matter of fact, a recent study found that coffee is the number one source of antioxidants in the U.S; not necessarily because it’s such a good source, but simply because Americans just drink so much of it. It you really want lots of antioxidants, instead of drinking more coffee, start eating more fruit. Blueberries, dates, and red grapes are especially high in antioxidants. Of course the real issue in most peoples minds is the caffeine content of this beverage. There’s no denying that caffeine can improve your mood and help fight fatigue. It can also act as a mild stimulant to improve physical and mental performance especially on monotonous tasks that you do over and over every day.
  • Download Product Insert (PDF)

    Download Product Insert (PDF)

    PRODUCT INFORMATION Proxyphylline Item No. 20937 CAS Registry No.: 603-00-9 Formal Name: 3,7-dihydro-7-(2-hydroxypropyl)-1,3- N dimethyl-1H-purine-2,6-dione O N Synonym: NSC 163343 C H N O MF: 10 14 4 3 N FW: 238.2 N Purity: ≥98% O UV/Vis.: λmax: 273, 324 nm Supplied as: A crystalline solid OH Storage: -20°C Stability: As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly Laboratory Procedures Proxyphylline is supplied as a crystalline solid. A stock solution may be made by dissolving the proxyphylline in the solvent of choice. Proxyphylline is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF), which should be purged with an inert gas. The solubility of proxyphylline in ethanol is approximately 1 mg/ml and approximately 10 mg/ml in DMSO and DMF. Further dilutions of the stock solution into aqueous buffers or isotonic saline should be made prior to performing biological experiments. Ensure that the residual amount of organic solvent is insignificant, since organic solvents may have physiological effects at low concentrations. Organic solvent-free aqueous solutions of proxyphylline can be prepared by directly dissolving the crystalline solid in aqueous buffers. The solubility of proxyphylline in PBS, pH 7.2, is approximately 1 mg/ml. We do not recommend storing the aqueous solution for more than one day. Description Proxyphylline is a methylxanthine derivative that has bronchodilatory actions.1 It has also been reported 2 to have vasodilatory and cardiac stimulatory effects.